| 1 |
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
Sarah C. Darby, Marianne Ewertz, Paul McGale et al. · New England Journal of Medicine
Open access |
13 Mar 2013 |
4,034 |
| 2 |
The repertoire of mutational signatures in human cancer
Ludmil B. Alexandrov et al. · Nature
Open access1,384 authors |
5 Feb 2020 |
3,854 |
| 3 |
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
Thierry André, Corrado Boni, Lamia Mounedji-Boudiaf et al. · New England Journal of Medicine
Open access |
2 Jun 2004 |
3,709 |
| 4 |
Pan-cancer analysis of whole genomes
Lauri A. Aaltonen et al. · Nature
Open access1,324 authors |
5 Feb 2020 |
3,360 |
| 5 |
International evaluation of an AI system for breast cancer screening
Scott Mayer McKinney et al. · Nature
Open access |
2020 |
3,314 |
| 6 |
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study
Eric A. J. Hoste et al. · Intensive Care Medicine
|
10 Jul 2015 |
3,174 |
| 7 |
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations
J. Nygren, J. Thacker, F. Carli et al. · World Journal of Surgery
Open access |
5 Oct 2012 |
2,179 |
| 8 |
Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations: 2018
Ulf O Gustafsson et al. · World Journal of Surgery
Open access |
13 Nov 2018 |
2,140 |
| 9 |
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
Nicholas David James et al. · The Lancet
Open access |
21 Dec 2015 |
1,985 |
| 10 |
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al. · Nature
Open access104 authors |
25 Apr 2017 |
1,978 |
| 11 |
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al. · The Lancet
Open access |
24 Jan 2017 |
1,953 |
| 12 |
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
Nicholas David James et al. · New England Journal of Medicine
Open access |
3 Jun 2017 |
1,806 |
| 13 |
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
Christopher M. Nutting, James P. Morden, Kevin Joseph Harrington et al. · The Lancet Oncology
Open access |
14 Jan 2011 |
1,721 |
| 14 |
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
Marko M. Babjuk, Maximilian Burger, Otakar Čapoun et al. · European Urology
|
9 Sep 2021 |
1,707 |
| 15 |
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
Robert E. Mansel, Lesley J. Fallowfield, Mark W. Kissin et al. · JNCI Journal of the National Cancer Institute
|
2 May 2006 |
1,692 |
| 16 |
Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
on behalf of the Acute Disease Quality Initiative Workgroup 16. et al. · Nature Reviews Nephrology
ReviewOpen access |
26 Feb 2017 |
1,573 |
| 17 |
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Sean T Kehoe, Jane Hook, Matthew Guy Nankivell et al. · The Lancet
|
20 May 2015 |
1,425 |
| 18 |
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Paul Dearnaley et al. · The Lancet Oncology
Open access |
22 Jun 2016 |
1,350 |
| 19 |
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
Marko M. Babjuk, Maximilian Burger, Éva Compérat et al. · European Urology
|
20 Aug 2019 |
1,344 |
| 20 |
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher Parker et al. · The Lancet
Open access |
21 Oct 2018 |
1,289 |
| 21 |
The evolutionary history of 2,658 cancers
Moritz Gerstung et al. · Nature
Open access1,441 authors |
5 Feb 2020 |
1,149 |
| 22 |
Mapping the human genetic architecture of COVID-19
COVID-19 Host Genetics Initiative et al. · Nature
Open access3,896 authors |
8 Jul 2021 |
1,130 |
| 23 |
Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS ® ) Society Recommendations
Ulf O Gustafsson, Michael J. Scott, W. Schwenk et al. · World Journal of Surgery
Open access |
5 Oct 2012 |
1,099 |
| 24 |
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
Hisham Mohamed Mehanna et al. · The Lancet
Open access |
15 Nov 2018 |
1,057 |
| 25 |
Patterns of somatic structural variation in human cancer genomes
Yilong Li et al. · Nature
Open access1,411 authors |
5 Feb 2020 |
1,005 |
| 26 |
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Morgan Rouprêt, Marko M. Babjuk, Maximilian Burger et al. · European Urology
Open access |
24 Jun 2020 |
951 |
| 27 |
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Stu, David L Russell-Jones, Allan Arthur Vaag et al. · Diabetologia
Open access |
13 Aug 2009 |
835 |
| 28 |
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Isidro Cortés-Ciriano et al. · Nature Genetics
Open access1,407 authors |
5 Feb 2020 |
793 |
| 29 |
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Morgan Rouprêt, Marko M. Babjuk, Éva Compérat et al. · European Urology
|
Sep 2017 |
779 |
| 30 |
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines
Jean A. Klastersky, Julien de Naurois, K. V. I. Rolston et al. · Annals of Oncology
Open access |
Sep 2016 |
774 |
| 31 |
Volumetric modulated arc therapy: a review of current literature and clinical use in practice
May Teoh, Catharine H. Clark, Katie A. Wood et al. · British Journal of Radiology
Open access |
19 Oct 2011 |
767 |
| 32 |
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial
R.D. James, Rob Glynne‐Jones, Helen Margaret Meadows et al. · The Lancet Oncology
Open access |
9 Apr 2013 |
738 |
| 33 |
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell, Ian Chau, David Cunningham et al. · The Lancet Oncology
Open access |
17 Apr 2013 |
733 |
| 34 |
Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice
Aarne Feldheiser, Omer Aziz, Giorgio Maria Baldini et al. · Acta Anaesthesiologica Scandinavica
Open access |
30 Oct 2015 |
721 |
| 35 |
Magnesium: physiology and pharmacology
William John Fawcett, Elizabeth J. Haxby, D. A. Male · British Journal of Anaesthesia
Open access |
Aug 1999 |
716 |
| 36 |
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Mitra K. Nadim et al. · Nature Reviews Nephrology
ReviewOpen access |
15 Oct 2020 |
715 |
| 37 |
Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
Esther Rheinbay et al. · Nature
Open access1,621 authors |
5 Feb 2020 |
674 |
| 38 |
Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations
Emmanuel Melloul, Martin Hübner, Michael J. Scott et al. · World Journal of Surgery
Open access |
22 Aug 2016 |
639 |
| 39 |
Additional factors for the estimation of mean glandular breast dose using the UK mammography dosimetry protocol
David R. Dance, C L Skinner, Kenneth C. Young et al. · Physics in Medicine and Biology
|
10 Oct 2000 |
628 |
| 40 |
Genetic cause of hyperglycaemia and response to treatment in diabetes
Ewan R. Pearson, Bryan J. Starkey, Roy J Powell et al. · The Lancet
|
Oct 2003 |
613 |
| 41 |
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Hugo E. R. Ford, Andrea Marshall, John A. Bridgewater et al. · The Lancet Oncology
Open access |
9 Dec 2013 |
609 |
| 42 |
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
Rachel F. Gabitass, Nicola E. Annels, Deborah D. Stocken et al. · Cancer Immunology Immunotherapy
Open access |
4 Jun 2011 |
575 |
| 43 |
Guidelines for postoperative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations — Part II
Gregg S Nelson, Alon D. Altman, Alpa Manchandia Nick et al. · Gynecologic Oncology
Open access |
4 Jan 2016 |
570 |
| 44 |
Insulin‐associated weight gain in diabetes – causes, effects and coping strategies
David L Russell-Jones, Rehman Khan · Diabetes Obesity and Metabolism
|
15 Dec 2006 |
565 |
| 45 |
Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019
Emmanuel Melloul, Kristoffer Lassen, Didier Roulin et al. · World Journal of Surgery
Open access |
11 Mar 2020 |
541 |
| 46 |
Mismatch Repair Deficiency, Microsatellite Instability, and Survival
Elizabeth Catherine Smyth, Andrew Charles Wotherspoon, Clare Peckitt et al. · JAMA Oncology
Open access |
27 Feb 2017 |
536 |
| 47 |
European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication
L. von Karsa et al. · Endoscopy
Open access109 authors |
4 Dec 2012 |
536 |
| 48 |
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update
Morgan Rouprêt, Thomas Seisen, Alison Jane Birtle et al. · European Urology
Open access |
24 Mar 2023 |
531 |
| 49 |
36th International Symposium on Intensive Care and Emergency Medicine
R. M. Bateman et al. · Critical Care
Open access2,440 authors |
Apr 2016 |
531 |
| 50 |
1 Hysterectomy: a historical perspective
Chris Sutton · Baillière s Clinical Obstetrics and Gynaecology
|
Mar 1997 |
531 |